BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 31

• BioForest

  Adaptive Biotech To Present 2 Studies Demonstrating Utility Of Immunosequencing To Propel Diagnostic Development And Therapeutic Discovery At The 2016 American Association Of Immunologists Annual Meeting

  May 16, 2016

   · 

  1 min read
• Lone Star Bio

  Neos Therapeutics Announces U.S. Launch Of Adzenys XR-ODT (Amphetamine Extended-Release Orally Disintegrating Tablet) For The Treatment Of ADHD In Patients Six Years And Older

  May 16, 2016

   · 

  8 min read
• Business

  The Medicines Company Appoints Tony Kingsley As President And Chief Operating Officer

  May 16, 2016

   · 

  3 min read
• Drug Development

  Merck & Co. Release: New KEYTRUDA (Pembrolizumab) Data At 2016 ASCO Annual Meeting Includes Three-Year Overall Survival Data In Melanoma And Updated Overall Survival Data In Non-Small Cell Lung Cancer As Well As Updated Findings In Head And Neck Cancer

  May 16, 2016

   · 

  1 min read
• FDA

  Thermo Fisher Scientific Receives FDA Clearance For EliA Anti-Thyroglobulin And Anti-Thyroid Peroxidase Tests For Autoimmune Thyroid Disease

  May 16, 2016

   · 

  2 min read
• Business

  ReCor Medical Announces Collaboration And Investment With Otsuka Holdings For Asian Commercialization And Clinical Studies In The US And Europe

  May 16, 2016

   · 

  3 min read
• Deals

  DiaSorin S.p.A. Completes Acquisition Of The Focus Diagnostics’ Molecular And Immunoassay Product Business From Quest Diagnostics

  May 16, 2016

   · 

  2 min read
• Business

  Mundipharma And Purdue Pharma L.P. Expand Pain Pipeline With New Deal For First-In-Class Sigma-1 Antagonist (S1A Or MR309/E-52862) From ESTEVE

  May 16, 2016

   · 

  5 min read
• Business

  Galmed Pharmaceuticals Reports First Quarter 2016 Financial Results And Provides Business Update

  May 16, 2016

   · 

  5 min read
• Genetown

  Biostage Announces $5 Million At-The-Market Offering

  May 16, 2016

   · 

  6 min read